What to Expect From Schlumberger's Next Quarterly Earnings Report
Ahead of this event, analysts expect Schlumberger to post adjusted earnings of $0.75 per share, down 11.8% from $0.85 per share reported in the same quarter last year. The company has surpassed Wall Street's bottom-line estimates in three of the past four quarters while missing on another occasion.
Holiday Trading, Trade Negotiations and Other Key Things to Watch this Week
Options Flow Alert: Bulls Making Their Move in GOOGL Stock
Jeff Bezos Unloads $5.4B in Amazon Shares: Should You Buy or Sell AMZN Stock Now?
Get exclusive insights with the FREE Barchart Brief newsletter. Subscribe now for quick, incisive midday market analysis you won't find anywhere else.
For fiscal 2025, analysts expect SLB to report an adjusted EPS of $3.07, a decline of nearly 10% from $3.41 in fiscal 2024. However, its earnings are expected to further grow 4.6% year-over-year to $3.21 in fiscal 2026.
Shares of SLB have declined 27.7% over the past 52 weeks, lagging behind the S&P 500 Index's ($SPX) 12.6% gain and the Energy Select Sector SPDR Fund's (XLE) 6.1% dip during the same period.
SLB stock fell 1.2% after its disappointing Q1 2025 results on Apr. 25. The company reported revenue of $8.5 billion, down 2.5% year-over-year, missing Street expectations. Adjusted EBITDA of $2 billion decreased 1.8% year-over-year with an adjusted EBITDA margin of 23.8%. Its adjusted EPS declined 4% from the prior-year quarter to $0.72 and fell short of analysts' estimates by 2.7%.
Furthermore, analysts' consensus view on Schlumberger is bullish, with an overall "Strong Buy" rating. Among 24 analysts covering the stock, 16 suggest a "Strong Buy," four give a "Moderate Buy," and four recommend a "Hold' rating. As of writing, SLB is trading below the mean price target of $47.63.
On the date of publication, Sohini Mondal did not have (either directly or indirectly) positions in any of the securities mentioned in this article. All information and data in this article is solely for informational purposes. This article was originally published on Barchart.com
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Hamilton Spectator
2 hours ago
- Hamilton Spectator
Telecom stocks help lift S&P/TSX composite in late-morning trading
TORONTO - Canada's main stock index was up in late-morning trading, helped by strength in the telecom sector. The S&P/TSX composite index was up 30.30 points at 27,064.56. The move on the Toronto market came with U.S. markets closed for the Fourth of July holiday. The Canadian dollar traded for 73.48 cents US compared with 73.66 cents US on Thursday. The August crude oil contract was down 44 cents US at US$66.56 per barrel. The August gold contract was up 40 cents US at US$3,343.30 an ounce. This report by The Canadian Press was first published July 4, 2025. Companies in this story: (TSX:GSPTSE, TSX:CADUSD)
Yahoo
3 hours ago
- Yahoo
Should You Invest in Schlumberger (SLB) Based on Bullish Wall Street Views?
The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side) analysts changing their ratings often affect a stock's price. Do they really matter, though? Let's take a look at what these Wall Street heavyweights have to say about Schlumberger (SLB) before we discuss the reliability of brokerage recommendations and how to use them to your advantage. Schlumberger currently has an average brokerage recommendation (ABR) of 1.40, on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell, etc.) made by 25 brokerage firms. An ABR of 1.40 approximates between Strong Buy and Buy. Of the 25 recommendations that derive the current ABR, 18 are Strong Buy and four are Buy. Strong Buy and Buy respectively account for 72% and 16% of all recommendations. Check price target & stock forecast for Schlumberger here>>> While the ABR calls for buying Schlumberger, it may not be wise to make an investment decision solely based on this information. Several studies have shown limited to no success of brokerage recommendations in guiding investors to pick stocks with the best price increase potential. Do you wonder why? As a result of the vested interest of brokerage firms in a stock they cover, their analysts tend to rate it with a strong positive bias. According to our research, brokerage firms assign five "Strong Buy" recommendations for every "Strong Sell" recommendation. In other words, their interests aren't always aligned with retail investors, rarely indicating where the price of a stock could actually be heading. Therefore, the best use of this information could be validating your own research or an indicator that has proven to be highly successful in predicting a stock's price movement. With an impressive externally audited track record, our proprietary stock rating tool, the Zacks Rank, which classifies stocks into five groups, ranging from Zacks Rank #1 (Strong Buy) to Zacks Rank #5 (Strong Sell), is a reliable indicator of a stock's near-term price performance. So, validating the Zacks Rank with ABR could go a long way in making a profitable investment decision. Although both Zacks Rank and ABR are displayed in a range of 1--5, they are different measures altogether. Broker recommendations are the sole basis for calculating the ABR, which is typically displayed in decimals (such as 1.28). The Zacks Rank, on the other hand, is a quantitative model designed to harness the power of earnings estimate revisions. It is displayed in whole numbers -- 1 to 5. Analysts employed by brokerage firms have been and continue to be overly optimistic with their recommendations. Since the ratings issued by these analysts are more favorable than their research would support because of the vested interest of their employers, they mislead investors far more often than they guide. On the other hand, earnings estimate revisions are at the core of the Zacks Rank. And empirical research shows a strong correlation between trends in earnings estimate revisions and near-term stock price movements. Furthermore, the different grades of the Zacks Rank are applied proportionately across all stocks for which brokerage analysts provide earnings estimates for the current year. In other words, at all times, this tool maintains a balance among the five ranks it assigns. There is also a key difference between the ABR and Zacks Rank when it comes to freshness. When you look at the ABR, it may not be up-to-date. Nonetheless, since brokerage analysts constantly revise their earnings estimates to reflect changing business trends, and their actions get reflected in the Zacks Rank quickly enough, it is always timely in predicting future stock prices. In terms of earnings estimate revisions for Schlumberger, the Zacks Consensus Estimate for the current year has declined 1.5% over the past month to $3.04. Analysts' growing pessimism over the company's earnings prospects, as indicated by strong agreement among them in revising EPS estimates lower, could be a legitimate reason for the stock to plunge in the near term. The size of the recent change in the consensus estimate, along with three other factors related to earnings estimates, has resulted in a Zacks Rank #4 (Sell) for Schlumberger. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>> Therefore, it could be wise to take the Buy-equivalent ABR for Schlumberger with a grain of salt. Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Schlumberger Limited (SLB) : Free Stock Analysis Report This article originally published on Zacks Investment Research ( Zacks Investment Research Sign in to access your portfolio
Yahoo
3 hours ago
- Yahoo
Why Healthpeak (DOC) is a Top Momentum Stock for the Long-Term
For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. While you may have an investing style you rely on, finding great stocks is made easier with the Zacks Style Scores. These are complementary indicators that rate stocks based on value, growth, and/or momentum characteristics. For momentum investors, upward or downward trends in a stock's price or earnings outlook take precedent, so they'll want to zero in on the Momentum Style Score. This Score can pinpoint good times to build a position in a stock, using factors like one-week price change and the monthly percentage change in earnings estimates. Headquartered in Denver, CO, Healthpeak Properties, Inc. is a REIT in the United States that acquires, develops, manages, sells and leases a diverse portfolio of healthcare real estate related properties. It is an S&P 500 Index member. DOC boasts a Momentum Style Score of B and VGM Score of B, and holds a Zacks Rank #3 (Hold) rating. Shares of Healthpeak has seen some interesting price action recently; the stock is up 4.2% over the past one week and up 6.7% over the past four weeks. And in the last one-year period, DOC has lost 6.5%. As for the stock's trading volume, 6,305,713 shares on average were traded over the last 20 days. Momentum investors don't just pay attention to price changes; positive earnings play a crucial role, too. One analyst revised their earnings estimate upwards in the last 60 days for fiscal 2025. The Zacks Consensus Estimate has increased $0 to $1.85 per share. DOC boasts an average earnings surprise of 1.7%. With strong earnings growth, a good Zacks Rank, and top-tier Momentum and VGM Style Scores, investors should think about adding DOC to their portfolios. Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Healthpeak Properties, Inc. (DOC) : Free Stock Analysis Report This article originally published on Zacks Investment Research ( Zacks Investment Research Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
